New
HealthMore in Health→
Study links recombinant shingles shot to lower cardiovascular burden
Key Takeaways
- A U.S. natural experiment compared adults vaccinated just before and after the shift to the recombinant shingles vaccine.
- The recombinant vaccine was associated with a 9% lower seven-year cardiovascular burden versus the older live attenuated shot.
- Significant associations were reported for ischemic heart disease, heart failure, and ischemic stroke in males.
- The authors say the findings justify clinical trials and mechanistic studies rather than proving causation.
DE
DT Editorial Team··via nature.com
